Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis
Creators
- 1. Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE 19803 (United States)
- 2. Nemours/Alfred I. duPont Hospital for Children, Rockland Center I, 1701 Rockland Road, Wilmington, DE 19803 (United States)
Description
Curcumin (diferuloylmethane), the yellow pigment in the Asian spice turmeric, is a hydrophobic polyphenol from the rhizome of Curcuma longa. Because of its chemopreventive and chemotherapeutic potential with no discernable side effects, it has become one of the major natural agents being developed for cancer therapy. Accumulating evidence suggests that curcumin induces cell death through activation of apoptotic pathways and inhibition of cell growth and proliferation. The mitotic checkpoint, or spindle assembly checkpoint (SAC), is the major cell cycle control mechanism to delay the onset of anaphase during mitosis. One of the key regulators of the SAC is the anaphase promoting complex/cyclosome (APC/C) which ubiquitinates cyclin B and securin and targets them for proteolysis. Because APC/C not only ensures cell cycle arrest upon spindle disruption but also promotes cell death in response to prolonged mitotic arrest, it has become an attractive drug target in cancer therapy. Cell cycle profiles were determined in control and curcumin-treated medulloblastoma and various other cancer cell lines. Pull-down assays were used to confirm curcumin binding. APC/C activity was determined using an in vitro APC activity assay. We identified Cdc27/APC3, a component of the APC/C, as a novel molecular target of curcumin and showed that curcumin binds to and crosslinks Cdc27 to affect APC/C function. We further provide evidence that curcumin preferably induces apoptosis in cells expressing phosphorylated Cdc27 usually found in highly proliferating cells. We report that curcumin directly targets the SAC to induce apoptosis preferably in cells with high levels of phosphorylated Cdc27. Our studies provide a possible molecular mechanism why curcumin induces apoptosis preferentially in cancer cells and suggest that phosphorylation of Cdc27 could be used as a biomarker to predict the therapeutic response of cancer cells to curcumin
Availability note (English)
Available from http://dx.doi.org/10.1186/1471-2407-12-44; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296673Additional details
Identifiers
Publishing Information
- Journal Title
- BMC cancer (Online)
- Journal Volume
- 12
- Journal Page Range
- p. 44
- ISSN
- 1471-2407
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46102723
- Subject category
- S60: APPLIED LIFE SCIENCES; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- APOPTOSIS; CELL CYCLE; CURCUMIN; DRUGS; IN VITRO; INHIBITION; MITOSIS; NEOPLASMS; PHOSPHORYLATION; PIGMENTS; PROTEINS; SIDE EFFECTS; SPICES; THERAPY
- Descriptors DEC
- AROMATICS; CELL DIVISION; CHEMICAL REACTIONS; DISEASES; DYES; ETHERS; HYDROXY COMPOUNDS; KETONES; MEDICINE; ORGANIC COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; PHENOLS; POLYPHENOLS
Optional Information
- Copyright
- Copyright (c)2012 Lee and Langhans
- Notes
- PMCID: PMC3296673; PUBLISHER-ID: 1471-2407-12-44; PMID: 22280307; OAI: oai:pubmedcentral.nih.gov:3296673; licensee BioMed Central Ltd.